3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
4
NETWORK
2
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Thoracic Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Interventions
pembrolizumab
133
Gemcitabine
101
Paclitaxel
100
Carboplatin
84
Nivolumab
65
Docetaxel
62
Bevacizumab
62
Cisplatin
57
Pemetrexed
50
Fluorouracil
49
Cyclophosphamide
41
Cetuximab
41
trametinib
38
venetoclax
37
Leucovorin
37
Irinotecan
37
Sorafenib
35
Capecitabine
35
Ipilimumab
33
Dexamethasone
32
atezolizumab
30
Erlotinib Hydrochloride
28
130-nm albumin-bound paclitaxel
28
Drug Therapy
27
Epoetin Alfa
26
Doxorubicin
25
Oxaliplatin
24
Albumin-Bound Paclitaxel
24
Rituximab
22
Prednisone
22
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Neoplasms
×
Patient Reported Outcome Measures
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled